Clinical Trials on Pulmonary Venoocclusive Disease in United Kingdom

Total 146984 results

University of Leicester
Aparito Ltd.

Not yet recruiting

Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD (INCLINE)

Chronic Obstructive Pulmonary Disease | Adherence, Treatment

United Kingdom
Research in Real-Life Ltd
Department of Health, United Kingdom

Completed

Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis

Chronic Obstructive Pulmonary Disease

United Kingdom
Portsmouth Hospitals NHS Trust

Suspended

A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients With COPD During Exacerbations and When Stable (SPIT-D)

Chronic Obstructive Pulmonary Disease

United Kingdom
NHS Tayside
NHS Fife

Withdrawn

Steroid Withdrawal Intervention in Fife and Tayside (SWIFT)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of East Anglia

Unknown

Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)

Emphysema | COPD

United Kingdom
Imperial College London

Completed

Macrophage Phagocytosis in COPD

Chronic Obstructive Pulmonary Disease | Emphysema | Chronic Bronchitis

United Kingdom
GlaxoSmithKline

Completed

Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients

Hypertension, Pulmonary

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London

Completed

Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
University Hospital Southampton NHS Foundation...
GlaxoSmithKline

Completed

Microbiology & Immunology of the Chronically-inflamed Airway (MICA)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pneumacare Ltd
Cambridge University Hospitals NHS Foundation Trust

Unknown

Validation of Structured Light Plethysmography - Health and Disease (SLP-RespDis)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Mrs Hanoof Aljohani
University Hospitals, Leicester

Recruiting

Home-based Body Weight Exercise With Blood Flow Restriction (BFR): Feasibility of a Novel Rehabilitation Intervention in COPD Patients (HomeBFR-COPD) (HomeBFR-COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca
Parexel

Completed

Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871

Chronic Obstructive Pulmonary Disease COPD

Germany, United Kingdom
Imperial College London
Medical Research Council

Completed

Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Royal United Hospitals Bath NHS Foundation Trust
Liverpool John Moores University

Enrolling by invitation

Applying Artificial Intelligence to the 12 Lead ECG for the Diagnosis of Pulmonary Hypertension: an Observational Study

Pulmonary Hypertension (Diagnosis)

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline; University of Cambridge; Royal Brompton & Harefield NHS Foundation... and other collaborators

Completed

Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. (EVOLUTION)

Chronic Obstructive Pulmonary Disease

United Kingdom
Oxford University Hospitals NHS Trust

Active, not recruiting

AI Assisted Detection of Chest X-Rays (AID-CXR)

Pneumoperitoneum | Pneumothorax | Cardiomegaly | Pleural Effusion | Atelectasis | Pulmonary Nodules, Solitary | Pneumothorax; Acute | Pleural Effusions, Chronic | Pulmonary Nodules, Multiple | Fibrosis Lung | Pulmonary Consolidation | Pulmonary Calcification

United Kingdom
Imperial College London

Completed

The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects (EXAP)

Idiopathic Pulmonary Arterial Hypertension

United Kingdom
Imperial College London
Melinta Therapeutics, Inc.

Terminated

A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United Kingdom
Sunovion Respiratory Development Inc.

Completed

Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (GOLDEN7)

COPD

United Kingdom
Hull University Teaching Hospitals NHS Trust
Galen Limited

Withdrawn

Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Completed

Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease

COPD

United Kingdom
Imperial College London
GlaxoSmithKline

Terminated

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

Chronic Obstructive Pulmonary Disease

United Kingdom
Patrick Murphy
ResMed; ResMed Foundation; Guy's & St Thomas' Charity; Respironics International

Completed

Home Mechanical Ventilation vs Home Oxygen Therapy in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London

Completed

Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Queen Mary University of London
GlaxoSmithKline; British Lung Foundation

Completed

Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care

Chronic Obstructive Pulmonary Disease

United Kingdom
Imperial College London
AstraZeneca

Withdrawn

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

Chronic Obstructive Pulmonary Disease (COPD) | Age Matched Healthy Volunteers (Non-smokers)

United Kingdom
AstraZeneca

Completed

The Use of a Forecasting System for Predicting Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Tetherex Pharmaceuticals Corporation

Completed

Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
GlaxoSmithKline

Not yet recruiting

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
Imperial College London

Unknown

Lung Volume Reduction Coil Microbiome Study (LVRC-Micro)

Chronic Obstructive Pulmonary Disease | Emphysema

United Kingdom
Imperial College London
AstraZeneca

Withdrawn

Markers for Chronic Obstructive Pulmonary Disease (COPD)

COPD Patients | Current Smokers | Healthy Non-smokers

United Kingdom
Imperial College London

Withdrawn

Systemic Endothelial Abnormalities in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
AstraZeneca
Simbec Research

Completed

A Scintigraphy Study of PT010 in COPD Patients (RD708/34000)

Chronic Obstructive Pulmonary Disease

United Kingdom
Liverpool Heart and Chest Hospital NHS Foundation...
Edge Hill University

Completed

Quality of Life in Pulmonary Rehabilitation: A Social Identity Based Intervention

Chronic Obstructive Pulmonary Disease

United Kingdom
Respivert Ltd

Completed

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Lincoln
National Health Service, United Kingdom

Completed

Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD (CIMPRES-COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
London School of Hygiene and Tropical Medicine
University College, London; British Medical Research Council

Completed

Survival After First Myocardial Infarction in Patients With and Without Chronic Obstructive Pulmonary Disease

Myocardial Infarction | Chronic Obstructive Pulmonary Disease

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Unknown

Intrinsic PEEP and Laryngeal Aperture in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Dr Ian B Wilkinson
University College London Hospitals; Imperial College London; Newcastle University and other collaborators

Recruiting

Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations (OPACE)

Chronic Obstructive Pulmonary Disease

United Kingdom
AstraZeneca

Completed

Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Unknown

The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)

Muscle Atrophy | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Imperial College London
Gene Logic

Completed

Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease

Emphysema | COPD

United Kingdom
Imperial College London
AstraZeneca

Withdrawn

GR Defect in Sputum Cells in COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pfizer

Completed

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
MedImmune LLC

Completed

Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese Participants

Part I (SAD) - Healthy Participants | Part II (MAD) - Chronic Obstructive Pulmonary Disease | Part III (J-SD) - Healthy Japanese Participants

United Kingdom
University College, London
South London and Maudsley NHS Foundation Trust

Active, not recruiting

Remote Assessment of Lung Disease and Impact on Physical and Mental Health (RALPMH)

Covid19 | Chronic Obstructive Pulmonary Disease | Interstitial Lung Disease

United Kingdom

Clinical Trials on Pulmonary Venoocclusive Disease in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations